1. Home
  2. UDMY vs WVE Comparison

UDMY vs WVE Comparison

Compare UDMY & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UDMY
  • WVE
  • Stock Information
  • Founded
  • UDMY 2009
  • WVE 2012
  • Country
  • UDMY United States
  • WVE Singapore
  • Employees
  • UDMY N/A
  • WVE N/A
  • Industry
  • UDMY Other Consumer Services
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • UDMY Real Estate
  • WVE Health Care
  • Exchange
  • UDMY Nasdaq
  • WVE Nasdaq
  • Market Cap
  • UDMY 1.1B
  • WVE 915.6M
  • IPO Year
  • UDMY 2021
  • WVE 2015
  • Fundamental
  • Price
  • UDMY $7.20
  • WVE $7.07
  • Analyst Decision
  • UDMY Buy
  • WVE Strong Buy
  • Analyst Count
  • UDMY 10
  • WVE 17
  • Target Price
  • UDMY $9.89
  • WVE $19.94
  • AVG Volume (30 Days)
  • UDMY 1.6M
  • WVE 2.4M
  • Earning Date
  • UDMY 10-28-2025
  • WVE 11-11-2025
  • Dividend Yield
  • UDMY N/A
  • WVE N/A
  • EPS Growth
  • UDMY N/A
  • WVE N/A
  • EPS
  • UDMY N/A
  • WVE N/A
  • Revenue
  • UDMY $795,538,000.00
  • WVE $93,946,000.00
  • Revenue This Year
  • UDMY $2.51
  • WVE N/A
  • Revenue Next Year
  • UDMY $4.18
  • WVE $10.02
  • P/E Ratio
  • UDMY N/A
  • WVE N/A
  • Revenue Growth
  • UDMY 3.93
  • WVE N/A
  • 52 Week Low
  • UDMY $5.68
  • WVE $5.28
  • 52 Week High
  • UDMY $10.61
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • UDMY 55.78
  • WVE 30.22
  • Support Level
  • UDMY $6.65
  • WVE $6.97
  • Resistance Level
  • UDMY $7.41
  • WVE $7.76
  • Average True Range (ATR)
  • UDMY 0.24
  • WVE 0.51
  • MACD
  • UDMY 0.05
  • WVE -0.32
  • Stochastic Oscillator
  • UDMY 76.40
  • WVE 1.87

About UDMY Udemy Inc.

Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The company operates under two operating and reportable segments Consumer and Enterprise, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: